Cargando…
Circulating Microvesicle-Associated Inducible Nitric Oxide Synthase Is a Novel Therapeutic Target to Treat Sepsis: Current Status and Future Considerations
To determine whether mitigating the harmful effects of circulating microvesicle-associated inducible nitric oxide (MV-A iNOS) in vivo increases the survival of challenged mice in three different mouse models of sepsis, the ability of anti-MV-A iNOS monoclonal antibodies (mAbs) to rescue challenged m...
Autores principales: | Webber, Robert J., Sweet, Richard M., Webber, Douglas S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705916/ https://www.ncbi.nlm.nih.gov/pubmed/34948167 http://dx.doi.org/10.3390/ijms222413371 |
Ejemplares similares
-
Effects of inducible nitric oxide synthase and neuronal nitric oxide synthase inhibition on methicillin-resistant Staphylococcus aureus sepsis
por: Bansal, Kamna, et al.
Publicado: (2008) -
Endothelial nitric oxide synthase is a regulator of hemodynamics in sepsis
por: Merx, M, et al.
Publicado: (2005) -
Circulating microvesicles in snakebite patients with microangiopathy
por: Enjeti, Anoop K., et al.
Publicado: (2018) -
Current status and therapeutic considerations of hypertension in the elderly
por: Lee, Ju-Hee, et al.
Publicado: (2019) -
Aldosterone synthase inhibitors in hypertension: current status and future possibilities
por: Hargovan, Milan, et al.
Publicado: (2014)